Jennifer Soung, MD, reacts to the FDA approval of roflumilast foam 0.3%
Roflumilast foam 0.3% trial investigator Jennifer Soung, MD, joined us to discuss the importance of this newly FDA-approved topical treatment for patients aged 12 years or older with scalp and body psoriasis.
Food Insecurity and the Dangers of Infant Formula Dilution
Social media potentially linked to depression in children
“These findings provide evidence that social media may be contributing to the development of depressive symptoms,” said Jason M. Nagata, MD, MSc.
Demystifying Infant Formula
FDA approves Jivi for patients aged 7 years and older with hemophilia A
The expanded indication follows original approval in August 2018 for use in previously-treated patients 12 years and older.
Maternal RSV vaccine data reveal uptake disparities
These findings come as many health care professionals still report limited confidence and inconsistent practices regarding RSV immunization discussions.
